President Bush named Cancer Center Member Robert J. Lefkowitz, MD, a recipient of the National Medal of Science for contributions to the biological sciences. Lefkowitz is being honored for a lifetime of research into understanding the largest, most important and most therapeutically accessible receptor system that controls the body's response to drugs and hormones.

President Bush will present Lefkowitz with the medal, which is the nation's highest honor for science, at a ceremony on Sept. 29 at the White House.

Andrew Armstrong, MD, has won a Young Investigator Award from the Prostate Cancer Foundation. The award focuses on the foundation's efforts on developing a gifted cohort of investigators to undertake the next generation of prostate cancer research.

Cancer biologists are turning their attention to the normal cells that give rise to cancers, to learn more about how tumor growth might be stopped at the earliest opportunity.

Many older people who have survived cancer five years or more take vitamins, minerals or other dietary supplements in hopes of remaining free of the disease.

In one of the first examinations of PSA screening in younger men, a study published by researchers at Duke Medicine's Prostate Center finds that one-fifth of men under age 50 reported undergoing a prostate specific antigen (PSA) test to detect prostate cancer in the previous year, yet only one in three young black men reported ever having a PSA test in the previous year.